Valeant in active talks on merger, acquisition deals
Feb 28 (Reuters) - Valeant Pharmaceuticals International Inc is in active discussions on large and small acquisitions or merger deals, Chief Executive Michael Pearson said on Thursday.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here